Lineage Cell Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of LCTX for the last quarter is 3.78 M USD, and it's 168.39% higher compared to the previous quarter. The net income of Q3 24 is -3.03 M USD.